
Pfizer Inc. announced Tuesday that it has asked the U.S. Food and Drug Administration to approve emergency use of its booster shot for children ages 5 to 11. The application hinges on a study of 140 children with no evidence of prior coronavirus infection. Their antibody levels against the original strain of the virus were… read on > read on >